In a recent article1 it was shown that 191, or 48 per cent., of patients with bronchial asthma were sensitive to some type of protein. In a more recent article2 the results of treatment with proteins of 100 of the sensitive patients was given; this 100 included only those patients who were sensitive to the proteins of animal hair and emanations and of food. The present paper concerns those patients who were treated with vaccines and represents a total of 178 individuals. Twenty-eight of these patients were sensitive to bacterial proteins, and therefore these patients were treated with vaccines of the organisms to which they were sensitive. The remaining 150 patients included in this paper were not sensitive to any protein with which they were tested. Since these nonsensitive patients are a part of the whole series of 400 cases, 48 per cent. of whom were found to be sensitive,
WALKER IC. THE TREATMENT OF BRONCHIAL ASTHMA WITH VACCINES. Arch Intern Med (Chic). 1919;23(2):220–234. doi:10.1001/archinte.1919.00090190090008
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: